QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Group, A.-R. E. D. S. R. Search for Related Content PubMed PubMed Citation Articles by Group, A.-R. E. D. S. R.

---

Supplement

The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants—Age-Related Eye Disease Study Report No. 2^{1 ,2}

³To whom correspondence and reprint request should be addressed: AREDS Coordinating Center, The EMMES Corporation, 11325 Seven Locks Road, Suite 214, Potomac, MD 20854. [A complete list of authors is provided in The Age-Related Eye Disease Study Research Group (1999 ).]

The Age-Related Eye Disease Study includes a clinical trial of high dose antioxidant and zinc supplements for age-related macular degeneration and a clinical trial of high dose antioxidants for cataract. The clinical trials were initiated largely because of the widespread public use in the United States of commercially available pharmacological doses of vitamins and minerals to treat these two eye conditions and the absence of definitive studies on the safety and efficacy of their use. This report focuses on the clinical trial of zinc and the possibility that this elderly study cohort, who were randomly assigned in a factorial design to receive zinc, antioxidants and placebo, could be assessed for zinc effects other than those currently addressed by the trial.

KEY WORDS: • zinc • age-related macular degeneration • cataract • clinical trial • antioxidants • vitamin C • vitamin E • beta-carotene

This article has been cited by other articles:

				Y.-Z. Wang, E. Wilson, K. G. Locke, and A. O. Edwards Shape Discrimination in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 2055 - 2062. [Abstract] [Full Text] [PDF]

				G. SOUBRANE and N. M BRESSLER Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy Br J Ophthalmol, April 1, 2001; 85(4): 483 - 495. [Full Text]

				H. J. Hyun, J. H. Sohn, D. W. Ha, Y. H. Ahn, J.-Y. Koh, and Y. H. Yoon Depletion of Intracellular Zinc and Copper with TPEN Results in Apoptosis of Cultured Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 460 - 465. [Abstract] [Full Text]